advertisement
International Journal of Pharmaceutics 8
Showing records 1 to 8 | Display all abstracts in International Journal of Pharmaceutics118498 Fabrication of architectonic nanosponges for intraocular delivery of Brinzolamide: An insight into QbD driven optimization, in vitro characterization, and pharmacodynamics
Bagul US
International Journal of Pharmaceutics 2024; 650: 123746
117145 Acetazolamide encapsulation in elastin like recombinamers using a supercritical antisolvent (SAS) process for glaucoma treatment
Vallejo R; Quinteros D
International Journal of Pharmaceutics 2024; 657: 124098
118498 Fabrication of architectonic nanosponges for intraocular delivery of Brinzolamide: An insight into QbD driven optimization, in vitro characterization, and pharmacodynamics
Nazirkar MV; Mane AK
International Journal of Pharmaceutics 2024; 650: 123746
117145 Acetazolamide encapsulation in elastin like recombinamers using a supercritical antisolvent (SAS) process for glaucoma treatment
Gutiérrez J; Martínez S
International Journal of Pharmaceutics 2024; 657: 124098
118498 Fabrication of architectonic nanosponges for intraocular delivery of Brinzolamide: An insight into QbD driven optimization, in vitro characterization, and pharmacodynamics
Khot SV; Tagalpallewar AA
International Journal of Pharmaceutics 2024; 650: 123746
117145 Acetazolamide encapsulation in elastin like recombinamers using a supercritical antisolvent (SAS) process for glaucoma treatment
Rodríguez Rojo S; Ignacio Tártara L
International Journal of Pharmaceutics 2024; 657: 124098
118498 Fabrication of architectonic nanosponges for intraocular delivery of Brinzolamide: An insight into QbD driven optimization, in vitro characterization, and pharmacodynamics
Kokare CR
International Journal of Pharmaceutics 2024; 650: 123746
117145 Acetazolamide encapsulation in elastin like recombinamers using a supercritical antisolvent (SAS) process for glaucoma treatment
Palma S; Javier Arias F
International Journal of Pharmaceutics 2024; 657: 124098
